Summit Financial Wealth Advisors, LLC Abb Vie Inc. Transaction History

Summit Financial Wealth Advisors, LLC

$505 Million
Q3 2024

A detailed history of Summit Financial Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Summit Financial Wealth Advisors, LLC holds 5,750 shares of ABBV stock, worth $1.02 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

5,750

Previous 5,750 -0.0%

Holding current value

$1.02 Million

Previous $986,000 15.11%

% of portfolio

0.22%

Previous 0.22%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $34,041 - $38,787	213 Added 3.85%	5,750 $1.05 Million
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $39,904 - $44,941	290 Added 5.53%	5,537 $858,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $26,851 - $31,084	-201 Reduced 3.69%	5,247 $782,000
Q1 2023 Apr 10, 2023	SELL	$144.61 - $166.54 $47,142 - $54,292	-326 Reduced 5.65%	5,448 $868,000
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $9,394 - $10,775	-70 Reduced 1.2%	5,774 $886,000
Q2 2022 Jul 26, 2022	BUY	$137.62 - $174.96 $48,717 - $61,935	354 Added 6.45%	5,844 $878,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $13,197 - $16,375	-100 Reduced 1.79%	5,490 $890,000
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $9,682 - $10,990	91 Added 1.65%	5,590 $603,000
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $4,839 - $5,391	-46 Reduced 0.83%	5,499 $619,000
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $58,413 - $64,306	-571 Reduced 9.34%	5,545 $594,000
Q4 2020 Jan 11, 2021	SELL	$80.49 - $108.67 $53,123 - $71,722	-660 Reduced 9.74%	6,116 $536,000
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $19,673 - $23,090	-229 Reduced 3.27%	6,776 $598,000
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $18,782 - $25,134	256 Added 3.79%	7,005 $695,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $64 - $97	-1 Reduced 0.01%	6,749 $511,000
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $1,298 - $1,624	18 Added 0.27%	6,750 $567,000
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $1.11 Million - $1.34 Million	-17,688 Reduced 72.43%	6,732 $496,000
Q2 2019 Jul 16, 2019	SELL	$65.7 - $83.98 $3.84 Million - $4.91 Million	-58,511 Reduced 70.55%	24,420 $1.78 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $192,310 - $226,339	2,493 Added 3.1%	82,931 $6.89 Million
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $254,258 - $313,568	3,266 Added 4.23%	80,438 $7.42 Million
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $306,383 - $340,602	3,446 Added 4.67%	77,172 $6.88 Million
Q1 2018 Apr 09, 2018	BUY	$92.01 - $123.21 $2.74 Million - $3.67 Million	29,754 Added 67.67%	73,726 $6.98 Million
Q1 2018 Apr 06, 2018	SELL	$92.01 - $123.21 $3.59 Million - $4.8 Million	-38,968 Reduced 46.98%	43,972 $4.16 Million
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $56,601 - $62,068	632 Added 0.77%	82,940 $8.02 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $1.2 Million - $1.53 Million	17,183 Added 26.38%	82,308 $7.31 Million
Q2 2017 Aug 14, 2017	BUY	N/A	65,125	65,125 $4.72 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Wealth Advisors, LLC with notifications on news.

Account

Summit Financial Wealth Advisors, LLC Abb Vie Inc. Transaction History